Format
Items per page
Sort by

Send to:

Choose Destination

Results: 15

Cited In for PubMed (Select 21403896)

1.

Parkinson's disease: animal models and dopaminergic cell vulnerability.

Blesa J, Przedborski S.

Front Neuroanat. 2014 Dec 15;8:155. doi: 10.3389/fnana.2014.00155. eCollection 2014. Review.

2.

A phenotypic model recapitulating the neuropathology of Parkinson's disease.

Ferris CF, Marella M, Smerkers B, Barchet TM, Gershman B, Matsuno-Yagi A, Yagi T.

Brain Behav. 2013 Jul;3(4):351-66. doi: 10.1002/brb3.138. Epub 2013 Apr 17.

3.

Fungal-derived semiochemical 1-octen-3-ol disrupts dopamine packaging and causes neurodegeneration.

Inamdar AA, Hossain MM, Bernstein AI, Miller GW, Richardson JR, Bennett JW.

Proc Natl Acad Sci U S A. 2013 Nov 26;110(48):19561-6. doi: 10.1073/pnas.1318830110. Epub 2013 Nov 11.

4.

Reduced vesicular storage of catecholamines causes progressive degeneration in the locus ceruleus.

Taylor TN, Alter SP, Wang M, Goldstein DS, Miller GW.

Neuropharmacology. 2014 Jan;76 Pt A:97-105. doi: 10.1016/j.neuropharm.2013.08.033. Epub 2013 Sep 8.

5.

Vivo-morpholinos induced transient knockdown of physical activity related proteins.

Ferguson DP, Schmitt EE, Lightfoot JT.

PLoS One. 2013 Apr 22;8(4):e61472. doi: 10.1371/journal.pone.0061472. Print 2013.

6.

Analysis of vesicular monoamine transporter 2 polymorphisms in Parkinson's disease.

Brighina L, Riva C, Bertola F, Saracchi E, Fermi S, Goldwurm S, Ferrarese C.

Neurobiol Aging. 2013 Jun;34(6):1712.e9-13. doi: 10.1016/j.neurobiolaging.2012.12.020. Epub 2013 Jan 28.

7.

Circadian dysfunction may be a key component of the non-motor symptoms of Parkinson's disease: insights from a transgenic mouse model.

Willison LD, Kudo T, Loh DH, Kuljis D, Colwell CS.

Exp Neurol. 2013 May;243:57-66. doi: 10.1016/j.expneurol.2013.01.014. Epub 2013 Jan 24. Review.

8.

Functional genetic variants in the vesicular monoamine transporter 1 modulate emotion processing.

Lohoff FW, Hodge R, Narasimhan S, Nall A, Ferraro TN, Mickey BJ, Heitzeg MM, Langenecker SA, Zubieta JK, Bogdan R, Nikolova YS, Drabant E, Hariri AR, Bevilacqua L, Goldman D, Doyle GA.

Mol Psychiatry. 2014 Jan;19(1):129-39. doi: 10.1038/mp.2012.193. Epub 2013 Jan 22.

9.

VMAT1 deletion causes neuronal loss in the hippocampus and neurocognitive deficits in spatial discrimination.

Multani PK, Hodge R, Estévez MA, Abel T, Kung H, Alter M, Brookshire B, Lucki I, Nall AH, Talbot K, Doyle GA, Lohoff FW.

Neuroscience. 2013 Mar 1;232:32-44. doi: 10.1016/j.neuroscience.2012.11.023. Epub 2012 Nov 29.

10.

Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism.

Hauser DN, Hastings TG.

Neurobiol Dis. 2013 Mar;51:35-42. doi: 10.1016/j.nbd.2012.10.011. Epub 2012 Oct 12. Review.

11.

Catechol and aldehyde moieties of 3,4-dihydroxyphenylacetaldehyde contribute to tyrosine hydroxylase inhibition and neurotoxicity.

Vermeer LM, Florang VR, Doorn JA.

Brain Res. 2012 Sep 20;1474:100-9. doi: 10.1016/j.brainres.2012.07.048. Epub 2012 Jul 31.

12.

PET imaging a MPTP-induced mouse model of Parkinson's disease using the fluoropropyl-dihydrotetrabenazine analog [18F]-DTBZ (AV-133).

Toomey JS, Bhatia S, Moon LT, Orchard EA, Tainter KH, Lokitz SJ, Terry T, Mathis JM, Penman AD.

PLoS One. 2012;7(6):e39041. doi: 10.1371/journal.pone.0039041. Epub 2012 Jun 18.

13.

A fluorescent-based assay for live cell, spatially resolved assessment of vesicular monoamine transporter 2-mediated neurotransmitter transport.

Bernstein AI, Stout KA, Miller GW.

J Neurosci Methods. 2012 Aug 15;209(2):357-66. doi: 10.1016/j.jneumeth.2012.06.002. Epub 2012 Jun 12.

14.

Overexpression of VMAT-2 and DT-diaphorase protects substantia nigra-derived cells against aminochrome neurotoxicity.

Muñoz P, Paris I, Sanders LH, Greenamyre JT, Segura-Aguilar J.

Biochim Biophys Acta. 2012 Jul;1822(7):1125-36. doi: 10.1016/j.bbadis.2012.03.010. Epub 2012 Mar 27.

15.

Tracking extranigral degeneration in animal models of Parkinson's disease: quest for effective therapeutic strategies.

Knaryan VH, Samantaray S, Le Gal C, Ray SK, Banik NL.

J Neurochem. 2011 Aug;118(3):326-38. doi: 10.1111/j.1471-4159.2011.07320.x. Epub 2011 Jun 17. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk